Two Sigma Securities, LLC Pasithea Therapeutics Corp. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$16.52 - $27.0 $312,211 - $510,273
-18,899 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$19.4 - $35.8 $366,640 - $676,584
18,899 New
18,899 $25,000
Q4 2021

Feb 14, 2022
SELL
$28.8 - $112.0 $300,672 - $1.17 Million
-10,440 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$54.8 - $71.2 $572,112 - $743,328
10,440 New
10,440 $32,000

About Pasithea Therapeutics Corp.

KTTA Quotes by TradingView
  • Ticker KTTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,398,700
  • Market Cap $89.4M
  • Description
  • Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...
More about KTTA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email